Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AXSM Axsome Therapeutics > Detailed Quotes

AXSM Axsome Therapeutics

44.620
+0.470+1.06%
Close 09/30 16:00 ET
44.6200.0000.00%
Post Mkt Price 09/30 16:00 ET
High
46.570
Open
44.260
Turnover
49.09M
Low
44.011
Pre Close
44.150
Volume
1.09M
Market Cap
1.91B
P/E(TTM)
Loss
52wk High
71.980
Shares
42.88M
P/E(Static)
Loss
52wk Low
20.630
Float Cap
1.56B
Bid/Ask %
33.33%
Historical High
109.940
Shs Float
34.88M
Volume Ratio
0.79
Historical Low
1.940
Dividend TTM
--
Div Yield TTM
--
P/B
126.05
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.11%
Amplitude
5.80%
Avg Price
45.237
Lot Size
1
Float Cap
1.56B
Bid/Ask %
33.33%
Historical High
109.940
Shs Float
34.88M
Volume Ratio
0.79
Historical Low
1.940
Dividend TTM
--
P/B
126.05
Dividend LFY
--
Turnover Ratio
3.11%
Amplitude
5.80%
Avg Price
45.237
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
CEO: Dr. Herriot Tabuteau, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...